Erratum: Activation of Dopamine D2 Receptor Suppresses Neuroinflammation Through αb-Crystalline by Inhibition of NF-κB Nuclear Translocation in Experimental ICH Mice Model (Stroke (2015) 46 (2637-2646) DOI: 10.1161/STROKEAHA.115.009792);Activation of Dopamine D2 Receptor Suppresses Neuroinflammation Through αb-Crystalline by Inhibition of NF-κB Nuclear Translocation in Experimental ICH Mice Model

Stroke

Volumn 46, Issue 9, 2015, Pages 2637-2646

  Zhang, Yang ^a,b   Chen, Yujie ^a,b   Wu, Jiang ^b,c   Manaenko, Anatol ^b   Yang, Peng ^b   Tang, Jiping ^b   Fu, Weiling ^a   Zhang, John H ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

B crystalline; dopamine D2 receptor; intracerebral hemorrhage; neuroinflammation; NF B

Indexed keywords

ALPHA B CRYSTALLIN; ALPHA CRYSTALLIN; CLOSTRIDIOPEPTIDASE A; COLONY STIMULATING FACTOR 1; CXCL9 CHEMOKINE; DOPAMINE 2 RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 16; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEURON SPECIFIC NUCLEAR PROTEIN; QUINPIROLE; ROPINIROLE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN WATER; CONTROLLED STUDY; CYTOPLASM; GENE SILENCING; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; IN VIVO STUDY; MACROPHAGE ACTIVATION; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; ACTIVE TRANSPORT; ANIMAL; CELL NUCLEUS; DISEASE MODEL; INBRED MOUSE STRAIN; INFLAMMATION; METABOLISM;

ACTIVE TRANSPORT, CELL NUCLEUS; ALPHA-CRYSTALLIN B CHAIN; ANIMALS; CELL NUCLEUS; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MICE; MICE, INBRED STRAINS; NF-KAPPA B; RECEPTORS, DOPAMINE D2;

EID: 84940397939     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STR.0000000000000390     Document Type: Erratum

References (35)

1. Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11:720-731. doi: 10.1016/S1474-4422(12)70104-7.
2. Zhou Y, Wang Y, Wang J, Anne Stetler R, Yang QW. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol. 2014;115:25-44. doi: 10.1016/j.pneurobio.2013.11.003.
3. Wang J, Doré S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007;27:894-908. doi: 10.1038/sj.jcbfm.9600403.
4. Ma Q, Chen S, Hu Q, Feng H, Zhang JH, Tang J. NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage. Ann Neurol. 2014;75:209-219. doi: 10.1002/ana.24070.
5. Wang J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol. 2010;92:463-477. doi: 10.1016/j.pneurobio.2010.08.001.
6. Iadecola C, Anrather J. Stroke research at a crossroad: asking the brain for directions. Nat Neurosci. 2011;14:1363-1368. doi: 10.1038/nn.2953.
7. Bibb JA. Decoding dopamine signaling. Cell. 2005;122:153-155. doi: 10.1016/j.cell.2005.07.011.
8. Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S. The immunoregulatory role of dopamine: an update. Brain Behav Immun. 2010;24:525-528. doi: 10.1016/j.bbi.2009.10.015.
9. Kuric E, Wieloch T, Ruscher K. Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke. Exp Neurol. 2013;247:202-208. doi: 10.1016/j.expneurol.2013.04.016.
10. Kuric E, Ruscher K. Reduction of rat brain CD8+ T-cells by levodopa/benserazide treatment after experimental stroke. Eur J Neurosci. 2014;40:2463-2470. doi: 10.1111/ejn.12598.
11. Kuric E, Ruscher K. Reversal of stroke induced lymphocytopenia by levodopa/benserazide treatment. J Neuroimmunol. 2014;269:94-97. doi: 10.1016/j.jneuroim.2014.02.009.
12. Laengle UW, Markstein R, Pralet D, Seewald W, Roman D. Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells. Exp Eye Res. 2006;83:1335-1339. doi: 10.1016/j.exer.2006.07.008.
13. Shao W, Zhang SZ, Tang M, Zhang XH, Zhou Z, Yin YQ, et al. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin. Nature. 2013;494:90-94. doi: 10.1038/nature11748.
14. Brownell SE, Becker RA, Steinman L. The protective and therapeutic function of small heat shock proteins in neurological diseases. Front Immunol. 2012;3:74. doi: 10.3389/fimmu.2012.00074.
15. Klopstein A, Santos-Nogueira E, Francos-Quijorna I, Redensek A, David S, Navarro X, et al. Beneficial effects of αB-crystallin in spinal cord contusion injury. J Neurosci. 2012;32:14478-14488. doi: 10.1523/JNEUROSCI.0923-12.2012.
16. Rothbard JB, Kurnellas MP, Brownell S, Adams CM, Su L, Axtell RC, et al. Therapeutic effects of systemic administration of chaperone αBcrystallin associated with binding proinflammatory plasma proteins. J Biol Chem. 2012;287:9708-9721. doi: 10.1074/jbc.M111.337691.
17. Ousman SS, Tomooka BH, van Noort JM, Wawrousek EF, O'Connor KC, Hafler DA, et al. Protective and therapeutic role for alphaBcrystallin in autoimmune demyelination. Nature. 2007;448:474-479. doi: 10.1038/nature05935.
18. Arac A, Brownell SE, Rothbard JB, Chen C, Ko RM, Pereira MP, et al. Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci U S A. 2011;108:13287-13292. doi: 10.1073/pnas.1107368108.
19. Krafft PR, Caner B, Klebe D, Rolland WB, Tang J, Zhang JH. PHA-543613 preserves blood-brain barrier integrity after intracerebral hemorrhage in mice. Stroke. 2013;44:1743-1747. doi: 10.1161/STROKEAHA.111.000427.
20. Topkoru BC, Altay O, Duris K, Krafft PR, Yan J, Zhang JH. Nasal administration of recombinant osteopontin attenuates early brain injury after subarachnoid hemorrhage. Stroke. 2013;44:3189-3194. doi: 10.1161/STROKEAHA.113.001574.
21. Fessner A, Esser JS, Bluhm F, Grundmann S, Zhou Q, Patterson C, et al. The transcription factor HoxB5 stimulates vascular remodelling in a cytokine-dependent manner. Cardiovasc Res. 2014;101:247-255. doi: 10.1093/cvr/cvt244.
22. Chen Y, Zhang Y, Tang J, Liu F, Hu Q, Luo C, et al. Norrin protected blood-brain barrier via frizzled-4/β-catenin pathway after subarachnoid hemorrhage in rats. Stroke. 2015;46:529-536. doi: 10.1161/STROKEAHA.114.007265.
23. Jung JE, Kim GS, Chan PH. Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke. 2011;42:3574-3579. doi: 10.1161/STROKEAHA.111.626648.
24. Wang J, Tsirka SE. Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke. 2005;36:613-618. doi: 10.1161/01.STR.0000155729.12931.8f.
25. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006;5:53-63. doi: 10.1016/S1474-4422(05)70283-0.
26. Peiser C, Trevisani M, Groneberg DA, Dinh QT, Lencer D, Amadesi S, et al. Dopamine type 2 receptor expression and function in rodent sensory neurons projecting to the airways. Am J Physiol Lung Cell Mol Physiol. 2005;289:L153-L158. doi: 10.1152/ajplung.00222.2004.
27. Iravani MM, Sadeghian M, Leung CC, Tel BC, Rose S, Schapira AH, et al. Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response. Exp Neurol. 2008;212:522-531. doi: 10.1016/j.expneurol.2008.04.037.
28. Tanaka K, Kanno T, Yanagisawa Y, Yasutake K, Hadano S, Yoshii F, et al. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis. Exp Neurol. 2011;232:41-52. doi: 10.1016/j.expneurol.2011.08.001.
29. Ruscher K, Kuric E, Wieloch T. Levodopa treatment improves functional recovery after experimental stroke. Stroke. 2012;43:507-513. doi: 10.1161/STROKEAHA.111.638767.
30. Arrigo AP, Simon S, Gibert B, Kretz-Remy C, Nivon M, Czekalla A, et al. Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett. 2007;581:3665-3674. doi: 10.1016/j.febslet.2007.04.033.
31. Adhikari AS, Singh BN, Rao KS, Rao ChM. αB-crystallin, a small heat shock protein, modulates NF-κB activity in a phosphorylation-dependent manner and protects muscle myoblasts from TNF-α induced cytotoxicity. Biochim Biophys Acta. 2011;1813:1532-1542. doi: 10.1016/j.bbamcr.2011.04.009.
32. Dieterich LC, Huang H, Massena S, Golenhofen N, Phillipson M, Dimberg A. αB-crystallin/HspB5 regulates endothelial-leukocyte interactions by enhancing NF-κB-induced up-regulation of adhesion molecules ICAM-1, VCAM-1 and E-selectin. Angiogenesis. 2013;16:975-983. doi: 10.1007/s10456-013-9367-4.
33. Mercatelli N, Dimauro I, Ciafré SA, Farace MG, Caporossi D. AlphaBcrystallin is involved in oxidative stress protection determined by VEGF in skeletal myoblasts. Free Radic Biol Med. 2010;49:374-382. doi: 10.1016/j.freeradbiomed.2010.04.027.
34. Nair VD, Olanow CW, Sealfon SC. Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines. Biochem J. 2003;373(pt 1):25-32. doi: 10.1042/BJ20030017.
35. Mirones I, Angel Rodríguez-Milla M, Cubillo I, Mariñas-Pardo L, de la Cueva T, Zapata A, et al. Dopamine mobilizes mesenchymal progenitor cells through D2-class receptors and their PI3K/AKT pathway. Stem Cells. 2014;32:2529-2538. doi: 10.1002/stem.1745.